CliffBio
small molecule

VICODIN HP

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Loss of exclusivity—loss of exclusivity
CompanyAbbVie Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameVICODIN HP
Active ingredientACETAMINOPHEN; HYDROCODONE BITARTRATE
Strength660MG;10MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalSeptember 1996
Marketing statusDISCN

More from AbbVie Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

VICODIN HP patent cliff — loss of exclusivity — | CliffBio